Jane Osbourn

Jane Osbourn

Company: Alchemab

Job title: Chief Scientific Officer


Panel Discussion: Investing in Neuroinflammatory Targets & Backing Smaller Companies Research 2:45 pm

• What do investors look for? • Improving the collaboration and funding efforts between pharma and biotech • Discussing the importance of investing in neuroscienceRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.